We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$27.2M
Cap. Flow
-$38M
Cap. Flow %
-20.28%
Top 10 Hldgs %
43.93%
Holding
89
New
25
Increased
12
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$5.07M
2
GILD icon
Gilead Sciences
GILD
+$4.16M
3
DXCM icon
DexCom
DXCM
+$2.66M
4
ETRM
EnteroMedics Inc.
ETRM
+$2.43M
5
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$2.39M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$4.51M
2
MRK icon
Merck
MRK
+$3.97M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.91M
4
STJ
St Jude Medical
STJ
+$3.64M
5
PBYI icon
Puma Biotechnology
PBYI
+$3.59M

Sector Composition

Rank Sector Weight
1 Healthcare 70.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBAY
51
DELISTED
Cymabay Therapeutics
CBAY
$855K 0.46%
+125,000
New +$768K
SNY icon
52
Sanofi
SNY
$104B
$846K 0.45%
+15,000
New +$806K
NPSP
53
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$845K 0.45%
32,500
-20,000
-38% -$574K
GWPH
54
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$809K 0.43%
+10,000
New +$885K
WMGI
55
CALL
DELISTED
Wright Medical Group Inc
WMGI
$758K 0.4%
+25,000
New +$770K
XLRN
56
DELISTED
Acceleron Pharma
XLRN
$756K 0.4%
25,000
-85,000
-77% -$2.39M
AGIO icon
57
PUT
Agios Pharmaceuticals
AGIO
$1.95B
$614K 0.33%
+10,000
New +$431K
TRNX
58
CALL
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$598K 0.32%
+25,000
New +$559K
VNDA icon
59
Vanda Pharmaceuticals
VNDA
$298M
$519K 0.28%
50,000
-50,000
-50% -$655K
ASMB icon
60
Assembly Biosciences
ASMB
$540M
$410K 0.22%
+4,167
New +$370K
EGLT
61
DELISTED
Egalet Corporation
EGLT
$200K 0.11%
35,000
-40,000
-53% -$420K
ETRM
62
CALL
DELISTED
EnteroMedics Inc.
ETRM
$87K 0.05%
+67
New +$98.2K
ABT icon
63
CALL
Abbott
ABT
$190B
– –
-50,000
Closed -$2.04M
AMGN icon
64
PUT
Amgen
AMGN
$224B
– –
-82,500
Closed -$9.77M
ASRT
65
DELISTED
Assertio
ASRT
– –
-2,083
Closed -$1.74M
ASRT
66
PUT
DELISTED
Assertio
ASRT
– –
-833
Closed -$695K
AVDL
67
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-25,000
Closed -$375K
CI icon
68
Cigna
CI
$72.4B
– –
-25,000
Closed -$2.3M
EW icon
69
PUT
Edwards Lifesciences
EW
$54B
– –
-150,000
Closed -$2.15M
HCA icon
70
HCA Healthcare
HCA
$89.1B
– –
-80,000
Closed -$4.51M
LGND icon
71
Ligand Pharmaceuticals
LGND
$5.76B
– –
-80,150
Closed -$3.12M
LGND icon
72
PUT
Ligand Pharmaceuticals
LGND
$5.76B
– –
-40,075
Closed -$1.56M
NUWE icon
73
CALL
Nuwellis
NUWE
$539K
– –
0
– -$420K
NUWE icon
74
Nuwellis
NUWE
$539K
– –
0
– -$560K
OEF icon
75
PUT
iShares S&P 100 ETF
OEF
$20.4B
– –
-75,000
Closed -$8.91M
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2014 Portfolio in Review

As of Q3 2014, Iguana Healthcare Management held 89 positions worth $187M, down 13% from $214M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Iguana Healthcare Management withdrew a net $38M in Q3 2014, closing 25 positions and reducing 22 holdings. Its most notable exit was HCA Healthcare, an estimated $4.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier.

Against the trend, Iguana Healthcare Management opened a new position in Zimmer Biomet worth $5.03M.

  • Iguana Healthcare Management's largest Q3 2014 buy was Zimmer Biomet: 51,500 shares worth $5.03M.
  • Iguana Healthcare Management added most to Gilead Sciences in Q3 2014, an estimated $4.16M increase.
  • Iguana Healthcare Management's biggest Q3 2014 reduction was Merck, cutting an estimated $3.97M.
  • Iguana Healthcare Management fully exited HCA Healthcare in Q3 2014, selling an estimated $4.51M.
  • Iguana Healthcare Management's ten largest holdings make up 44% of its $187M portfolio in Q3 2014.
  • Iguana Healthcare Management opened 25 new positions and closed 25 in Q3 2014.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $187M.

Based on Iguana Healthcare Management's 13F filing for Q3 2014, filed 14 Nov 2014.